Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC

INTRODUCTION: The East Asia S-1 Trial in Lung Cancer (EAST-LC) was a randomized phase III study conducted in East Asia that demonstrated the non-inferiority of S-1 to docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC). Here, we reported the results of the Japan...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugawara, Shunichi, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki, Nokihara, Hiroshi, Ohe, Yuichiro, Nishio, Makoto, Takahashi, Toshiaki, Goto, Koichi, Maemondo, Makoto, Ichinose, Yukito, Seto, Takashi, Sakai, Hiroshi, Gemma, Akihiko, Imamura, Fumio, Shingyoji, Masato, Saka, Hideo, Inoue, Akira, Takeda, Koji, Okamoto, Isamu, Kiura, Katsuyuki, Morita, Satoshi, Tamura, Tomohide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469651/
https://www.ncbi.nlm.nih.gov/pubmed/30830659
http://dx.doi.org/10.1007/s10147-019-01396-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469651/
https://www.ncbi.nlm.nih.gov/pubmed/30830659
http://dx.doi.org/10.1007/s10147-019-01396-z

Ejemplares similares